Review

gdf15 (R&D Systems)

R&D Systems is a verified supplier

R&D Systems manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

R&D Systems gdf15
Gdf15, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 233 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gdf15/product/R&D Systems
Average 96 stars, based on 233 article reviews

gdf15 - by Bioz Stars, 2026-06

96/100 stars

Images

Similar Products

anti gdf15 (MedChemExpress)

MedChemExpress anti gdf15
Anti Gdf15, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti gdf15/product/MedChemExpress
Average 94 stars, based on 1 article reviews

anti gdf15 - by Bioz Stars, 2026-06

94/100 stars

Buy from Supplier

gdf15 (Abmart Inc)

Abmart Inc gdf15
Gdf15, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gdf15/product/Abmart Inc
Average 86 stars, based on 1 article reviews

gdf15 - by Bioz Stars, 2026-06

86/100 stars

Buy from Supplier

anti gdf15 monoclonal antibody (Pfizer Inc)

Pfizer Inc anti gdf15 monoclonal antibody
Anti Gdf15 Monoclonal Antibody, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti gdf15 monoclonal antibody/product/Pfizer Inc
Average 86 stars, based on 1 article reviews

anti gdf15 monoclonal antibody - by Bioz Stars, 2026-06

86/100 stars

Buy from Supplier

fc fused gdf15 binder exhibited neutralization potency (Pfizer Inc)

Pfizer Inc fc fused gdf15 binder exhibited neutralization potency
Fc Fused Gdf15 Binder Exhibited Neutralization Potency, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fc fused gdf15 binder exhibited neutralization potency/product/Pfizer Inc
Average 86 stars, based on 1 article reviews

fc fused gdf15 binder exhibited neutralization potency - by Bioz Stars, 2026-06

86/100 stars

Buy from Supplier

gdf15 binders (Twist Bioscience)

Twist Bioscience gdf15 binders
Gdf15 Binders, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gdf15 binders/product/Twist Bioscience
Average 86 stars, based on 1 article reviews

gdf15 binders - by Bioz Stars, 2026-06

86/100 stars

Buy from Supplier

gdf15 nugfp ce (Jackson Laboratory)

Jackson Laboratory gdf15 nugfp ce

a. Heatmap of secreted protein expression in liver on KD-5%P, KD-10%P and chow. b. Circulating <t>GDF15</t> levels of WT B6J mice fed with KD-5%P, KD-10%P and chow. c. Circulating FGF21 levels of WT B6J mice fed with KD-5%P, KD-10%P and chow. d. The schematic of ablating GFRAL-neurons in Area Postrema and the resulting body weight, cumulative calories consumed (kcal), and body composition of WT B6J mice under KD-5%P or KD-10%P. e. Body weight and cumulative calories consumed of B6NJ-GDF15 whole-body knockout and control mice under KD-5%P or KD-10%P. (n = 3 mice for DTA fed with KD-10%P and mCherry with KD-10%P; n=7 for DTA fed with KD-5%P and n=9 for mCherry fed with KD-5%P. GDF15-KO experiment has n=2 in each group. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Gdf15 Nugfp Ce, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gdf15 nugfp ce/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews

gdf15 nugfp ce - by Bioz Stars, 2026-06

86/100 stars

Buy from Supplier

gdf15 (R&D Systems)

R&D Systems gdf15

Gdf15, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gdf15/product/R&D Systems
Average 96 stars, based on 1 article reviews

gdf15 - by Bioz Stars, 2026-06

96/100 stars

Buy from Supplier

mouse rat gdf15 quantikine elisa kit (R&D Systems)

R&D Systems mouse rat gdf15 quantikine elisa kit

a, Daily food intake (g per mouse) measured in HFD-fed mice receiving daily intraperitoneal injections of vehicle (VEH) or BAY2402234 (BAY) at ZT0 or ZT12 for 7 consecutive days (n=20/group). b, Distribution of food intake between light and dark phases for the same conditions as in ( a) (n=4 cages/group). c, Representative immunoblots of hepatic FGF21 collected 4 h and 16 h after VEH or BAY injection at ZT0 (top) or ZT12 (bottom). LC, loading control. n=4/group/timepoint. d, Densitometric quantification of FGF21 normalized to LC at 4 h and 16 h after injection; ns, not significant; P < 0.05. e,g, Serum <t>GDF15</t> measured 4 h and 16 h after VEH or BAY injection at ZT0 ( e ; sampling at ZT4 and ZT16) or ZT12 ( g ; sampling at ZT16 and ZT4), respectively. n=4/group/timepoint. f,h, Daily water intake following injections at ZT0 ( f ) or ZT12 ( h ). n=8/group/timepoint. Data are mean ± s.e.m. Statistical comparisons were performed between VEH and BAY at each matched time point; ns, not significant; * P < 0.05. All experiments were performed in male C57BL/6J mice.

Mouse Rat Gdf15 Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse rat gdf15 quantikine elisa kit/product/R&D Systems
Average 96 stars, based on 1 article reviews

mouse rat gdf15 quantikine elisa kit - by Bioz Stars, 2026-06

96/100 stars

Buy from Supplier

gdf15 (Galectin Therapeutics)

Galectin Therapeutics gdf15

Gdf15, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gdf15/product/Galectin Therapeutics
Average 86 stars, based on 1 article reviews

gdf15 - by Bioz Stars, 2026-06

86/100 stars

Buy from Supplier

Image Search Results

a. Heatmap of secreted protein expression in liver on KD-5%P, KD-10%P and chow. b. Circulating GDF15 levels of WT B6J mice fed with KD-5%P, KD-10%P and chow. c. Circulating FGF21 levels of WT B6J mice fed with KD-5%P, KD-10%P and chow. d. The schematic of ablating GFRAL-neurons in Area Postrema and the resulting body weight, cumulative calories consumed (kcal), and body composition of WT B6J mice under KD-5%P or KD-10%P. e. Body weight and cumulative calories consumed of B6NJ-GDF15 whole-body knockout and control mice under KD-5%P or KD-10%P. (n = 3 mice for DTA fed with KD-10%P and mCherry with KD-10%P; n=7 for DTA fed with KD-5%P and n=9 for mCherry fed with KD-5%P. GDF15-KO experiment has n=2 in each group. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Journal: bioRxiv

Article Title: Macronutrient Composition and Genetic Background Determine the Response to a Ketogenic Diet

doi: 10.64898/2026.04.23.720368

Figure Lengend Snippet: a. Heatmap of secreted protein expression in liver on KD-5%P, KD-10%P and chow. b. Circulating GDF15 levels of WT B6J mice fed with KD-5%P, KD-10%P and chow. c. Circulating FGF21 levels of WT B6J mice fed with KD-5%P, KD-10%P and chow. d. The schematic of ablating GFRAL-neurons in Area Postrema and the resulting body weight, cumulative calories consumed (kcal), and body composition of WT B6J mice under KD-5%P or KD-10%P. e. Body weight and cumulative calories consumed of B6NJ-GDF15 whole-body knockout and control mice under KD-5%P or KD-10%P. (n = 3 mice for DTA fed with KD-10%P and mCherry with KD-10%P; n=7 for DTA fed with KD-5%P and n=9 for mCherry fed with KD-5%P. GDF15-KO experiment has n=2 in each group. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Article Snippet: Wild-type C57BL/6J (#000664), C57BL/6NJ (#005304), FVB/NJ(#001800), DBA/2J (# 000671), Fgf21-KO (B6.129Sv(Cg)-Fgf21 tm1.1Djm /J, #033846), Gfral-cre(B6;SJL-Gfral em1(cre)Rsy /J, #036750), Gdf15 nuGFP-CE (C57BL/6 Gdf15tm1(cre/ERT2)Amc/J, 034497) were obtained from Jackson Lab. OB F1 were obtained from Jackson Lab, then bred in lab, from crossing male OB and female ob/+(#000632).

Techniques: Expressing, Knock-Out, Control

a. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of mice ablating GFRAL-neurons in Area Postrema and control mice under KD-5%P or KD-10%P. b. Serum glucose levels of B6NJ-Gdf15 whole-body knockout mice under KD-5%P or KD-10%P. c. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of WT B6J or B6NJ mice under KD-5%P or KD-10%P. d. Serum glucose levels of WT B6J or B6NJ mice under KD-5%P or KD-10%P. e. Serum ketone levels of WT B6J or B6NJ mice under KD-5%P or KD-10%P. f. Hepatic glycogen levels of WT B6J or B6NJ mice under KD-5%P or KD-10%P. g. Hepatic saponified fatty acids profiles of WT B6J or B6NJ mice under KD-5%P or KD-10%P. h. Body weight, cumulative calorie intake (Kcal), and body composition of female WT B6NJ mice under KD-5%P or KD-10%P. i. Circulating GDF15 levels of female WT B6NJ mice under KD-5%P or KD-10%P. j. Serum glucose levels of female WT B6NJ mice under KD-5%P or KD-10%P. k. Serum ketone levels of female WT B6NJ mice under KD-5%P or KD-10%P. l. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of female WT B6NJ mice under KD-5%P or KD-10%P. (n = 5 for all groups. All glucose/ketone are done by testing 2 individual days of the same group of mice. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Journal: bioRxiv

Article Title: Macronutrient Composition and Genetic Background Determine the Response to a Ketogenic Diet

doi: 10.64898/2026.04.23.720368

Figure Lengend Snippet: a. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of mice ablating GFRAL-neurons in Area Postrema and control mice under KD-5%P or KD-10%P. b. Serum glucose levels of B6NJ-Gdf15 whole-body knockout mice under KD-5%P or KD-10%P. c. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of WT B6J or B6NJ mice under KD-5%P or KD-10%P. d. Serum glucose levels of WT B6J or B6NJ mice under KD-5%P or KD-10%P. e. Serum ketone levels of WT B6J or B6NJ mice under KD-5%P or KD-10%P. f. Hepatic glycogen levels of WT B6J or B6NJ mice under KD-5%P or KD-10%P. g. Hepatic saponified fatty acids profiles of WT B6J or B6NJ mice under KD-5%P or KD-10%P. h. Body weight, cumulative calorie intake (Kcal), and body composition of female WT B6NJ mice under KD-5%P or KD-10%P. i. Circulating GDF15 levels of female WT B6NJ mice under KD-5%P or KD-10%P. j. Serum glucose levels of female WT B6NJ mice under KD-5%P or KD-10%P. k. Serum ketone levels of female WT B6NJ mice under KD-5%P or KD-10%P. l. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of female WT B6NJ mice under KD-5%P or KD-10%P. (n = 5 for all groups. All glucose/ketone are done by testing 2 individual days of the same group of mice. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Techniques: Control, Knock-Out

a. Body weight, cumulative calories consumed, and body composition of WT B6J and B6NJ mice under KD-5%P or KD-10%P. b. Serum GDF15 levels of WT B6J and B6NJ mice under KD-5%P or KD-10%P. c. The schematic of hepatic AAV-induced Nnt expression in B6J mice and the resulting body weight, cumulative calories consumed, and body composition of both groups under KD-5%P. d. Serum GDF15 levels of AAV-induced Nnt expression and control mice under KD-5%P. e, f. As in c, d, for B6NJ Nnt whole-body knockout mice. (n = 5 for each B6J and B6NJ group, n=5 for AAV-induced Nnt expression and control group. n=8 for Nnt-WT, n=7 for Nnt-KO. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Journal: bioRxiv

Article Title: Macronutrient Composition and Genetic Background Determine the Response to a Ketogenic Diet

doi: 10.64898/2026.04.23.720368

Figure Lengend Snippet: a. Body weight, cumulative calories consumed, and body composition of WT B6J and B6NJ mice under KD-5%P or KD-10%P. b. Serum GDF15 levels of WT B6J and B6NJ mice under KD-5%P or KD-10%P. c. The schematic of hepatic AAV-induced Nnt expression in B6J mice and the resulting body weight, cumulative calories consumed, and body composition of both groups under KD-5%P. d. Serum GDF15 levels of AAV-induced Nnt expression and control mice under KD-5%P. e, f. As in c, d, for B6NJ Nnt whole-body knockout mice. (n = 5 for each B6J and B6NJ group, n=5 for AAV-induced Nnt expression and control group. n=8 for Nnt-WT, n=7 for Nnt-KO. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Techniques: Expressing, Control, Knock-Out

a. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of Gfral-ablation and control mice under KD-5%P or KD-10%P. b. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of B6NJ-Nnt whole-body knockout mice under KD-5%P or KD-10%P. c. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of B6J mice with NNT re-expression under KD-5%P or KD-10%P. d. Body weight, cumulative calorie intake (Kcal) and body composition of DBA/2J mice on KD-5%P or KD-10%P. e. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of composition of DBA/2J mice under KD-5%P or KD-10%P. f. GDF15 levels of DBA/2J mice under KD-5%P or KD-10%P. g-i. As in d-f, for FVB/NJ mice. j. Western blot of Nnt in the liver of control or overexpression mice. (n = 5 for each group in DBA/2J, n=4 for each group in FVB/2J. All glucose/ketone are done by testing 2 individual days of the same group of mice. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Journal: bioRxiv

Article Title: Macronutrient Composition and Genetic Background Determine the Response to a Ketogenic Diet

doi: 10.64898/2026.04.23.720368

Figure Lengend Snippet: a. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of Gfral-ablation and control mice under KD-5%P or KD-10%P. b. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of B6NJ-Nnt whole-body knockout mice under KD-5%P or KD-10%P. c. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of B6J mice with NNT re-expression under KD-5%P or KD-10%P. d. Body weight, cumulative calorie intake (Kcal) and body composition of DBA/2J mice on KD-5%P or KD-10%P. e. Glucose tolerance test (2mg glucose/kg body weight) and calculated area under the curve of composition of DBA/2J mice under KD-5%P or KD-10%P. f. GDF15 levels of DBA/2J mice under KD-5%P or KD-10%P. g-i. As in d-f, for FVB/NJ mice. j. Western blot of Nnt in the liver of control or overexpression mice. (n = 5 for each group in DBA/2J, n=4 for each group in FVB/2J. All glucose/ketone are done by testing 2 individual days of the same group of mice. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Techniques: Control, Knock-Out, Expressing, Western Blot, Over Expression

a. Volcano plot of hepatic mRNA expression of B6J and B6NJ mice fed with KD-5%P versus KD-10%P at ad lib fasted state. b. Immune response pathway analysis between KD-5%P versus KD-10%P in B6J and B6NJ mice. c. Serum LCN2 levels of WT B6J and B6NJ mice under KD-5%P or KD-10%P. d. Body weight, cumulative calories consumed, and body composition of B6NJ-Nlrp12 whole-body knockout and littermate mice under KD-5%P or KD-10%P. e. Body weight, cumulative calories consumed (kcal) and body composition of B6J-Lcn2 whole-body knockout and littermate mice under KD-5%P or KD-10%P. f. Serum LCN2 levels of B6NJ-Nlrp12 whole-body knockout mice under KD-5%P or KD-10%P. g. Serum GDF15 levels of B6NJ-Nlrp12 whole-body knockout mice under KD-5%P or KD-10%P. (For a, b and d, n = 5 for each B6J and B6NJ group; n=10 for Nlrp12-KO under KD-5%P, n=8 for Nlrp12-KO under KD-10%P, and n=5 for both WT litter mate under 2 diets. For B6J-Lcn2 KO experiment, n=7 for KO under KD-5%P, n=5 for KO under KD-10%P and n=4 for WT under both diets. For serum Lcn2 and GDF15 measurement in B6NJ-Nlrp12-KO mice, n=5 for KD-10%P group and n=7 for KD-5%P group. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Journal: bioRxiv

Article Title: Macronutrient Composition and Genetic Background Determine the Response to a Ketogenic Diet

doi: 10.64898/2026.04.23.720368

Figure Lengend Snippet: a. Volcano plot of hepatic mRNA expression of B6J and B6NJ mice fed with KD-5%P versus KD-10%P at ad lib fasted state. b. Immune response pathway analysis between KD-5%P versus KD-10%P in B6J and B6NJ mice. c. Serum LCN2 levels of WT B6J and B6NJ mice under KD-5%P or KD-10%P. d. Body weight, cumulative calories consumed, and body composition of B6NJ-Nlrp12 whole-body knockout and littermate mice under KD-5%P or KD-10%P. e. Body weight, cumulative calories consumed (kcal) and body composition of B6J-Lcn2 whole-body knockout and littermate mice under KD-5%P or KD-10%P. f. Serum LCN2 levels of B6NJ-Nlrp12 whole-body knockout mice under KD-5%P or KD-10%P. g. Serum GDF15 levels of B6NJ-Nlrp12 whole-body knockout mice under KD-5%P or KD-10%P. (For a, b and d, n = 5 for each B6J and B6NJ group; n=10 for Nlrp12-KO under KD-5%P, n=8 for Nlrp12-KO under KD-10%P, and n=5 for both WT litter mate under 2 diets. For B6J-Lcn2 KO experiment, n=7 for KO under KD-5%P, n=5 for KO under KD-10%P and n=4 for WT under both diets. For serum Lcn2 and GDF15 measurement in B6NJ-Nlrp12-KO mice, n=5 for KD-10%P group and n=7 for KD-5%P group. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Techniques: Expressing, Knock-Out

a. Heatmap of mitochondrial stress gene markers of B6J mice fed with KD-5%P, KD-10%P and chow. b. Heatmap of oxidative stress gene markers of B6J mice fed with KD-5%P, KD-10%P and chow. c. The schematic of Isrib i.p. injection in B6J mice and the result body weight, cumulative food intake (Kcal) and body composition of both groups under KD-5%P or KD-10%P. d. Serum GDF15 levels of B6J mice treated with Isrib or Vehicle under KD-5%P or KD-10%P. e. Serum LCN2 levels of B6J mice treated with Isrib or Vehicle under KD-5%P or KD-10%P. f-h. As in c-e, for NAC treatment, control group is the same data. i. The schematic of the mechanism on how KD induces body weight loss (n = 5 mice for each group. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Journal: bioRxiv

Article Title: Macronutrient Composition and Genetic Background Determine the Response to a Ketogenic Diet

doi: 10.64898/2026.04.23.720368

Figure Lengend Snippet: a. Heatmap of mitochondrial stress gene markers of B6J mice fed with KD-5%P, KD-10%P and chow. b. Heatmap of oxidative stress gene markers of B6J mice fed with KD-5%P, KD-10%P and chow. c. The schematic of Isrib i.p. injection in B6J mice and the result body weight, cumulative food intake (Kcal) and body composition of both groups under KD-5%P or KD-10%P. d. Serum GDF15 levels of B6J mice treated with Isrib or Vehicle under KD-5%P or KD-10%P. e. Serum LCN2 levels of B6J mice treated with Isrib or Vehicle under KD-5%P or KD-10%P. f-h. As in c-e, for NAC treatment, control group is the same data. i. The schematic of the mechanism on how KD induces body weight loss (n = 5 mice for each group. Data are presented as mean ± s.e.m. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.)

Techniques: Injection, Control

Journal: bioRxiv

Article Title: Chronopharmacological targeting of mitochondrial dihydroorotate dehydrogenase prevents diet-induced obesity in male mice

doi: 10.64898/2026.04.18.719366

Figure Lengend Snippet: a, Daily food intake (g per mouse) measured in HFD-fed mice receiving daily intraperitoneal injections of vehicle (VEH) or BAY2402234 (BAY) at ZT0 or ZT12 for 7 consecutive days (n=20/group). b, Distribution of food intake between light and dark phases for the same conditions as in ( a) (n=4 cages/group). c, Representative immunoblots of hepatic FGF21 collected 4 h and 16 h after VEH or BAY injection at ZT0 (top) or ZT12 (bottom). LC, loading control. n=4/group/timepoint. d, Densitometric quantification of FGF21 normalized to LC at 4 h and 16 h after injection; ns, not significant; P < 0.05. e,g, Serum GDF15 measured 4 h and 16 h after VEH or BAY injection at ZT0 ( e ; sampling at ZT4 and ZT16) or ZT12 ( g ; sampling at ZT16 and ZT4), respectively. n=4/group/timepoint. f,h, Daily water intake following injections at ZT0 ( f ) or ZT12 ( h ). n=8/group/timepoint. Data are mean ± s.e.m. Statistical comparisons were performed between VEH and BAY at each matched time point; ns, not significant; * P < 0.05. All experiments were performed in male C57BL/6J mice.

Article Snippet: Serum GDF15 was measured with Mouse/Rat GDF15 Quantikine ELISA Kit (R&D Systems), following the manufacturer recommendations.

Techniques: Western Blot, Injection, Control, Sampling